Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Basak EA"'
Autor:
de Joode K; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Heersche N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Department of Radiology & Nuclear Medicine, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., van Schaik RHN; Department of Clinical Chemistry, Erasmus MC, Erasmus University Hospital, Rotterdam, the Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: a.mathijssen@erasmusmc.nl.
Publikováno v:
Cancer treatment reviews [Cancer Treat Rev] 2024 Jan; Vol. 122, pp. 102662. Date of Electronic Publication: 2023 Nov 27.
Autor:
Basak EA; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: e.basak@erasmusmc.nl., de Joode K; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Uyl TJJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Wal R; Dept. of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Schreurs MWJ; Dept. of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., van den Berg SAA; Dept. of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands; Dept. of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, the Netherlands., Oomen-de Hoop E; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Leest CH; Dept. of Pulmonology, Amphia Hospital, Breda, the Netherlands., Chaker L; Dept. of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Feelders RA; Dept. of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Veldt AAM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Joosse A; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Aerts JGJV; Dept. of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Bins S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie [Biomed Pharmacother] 2022 Dec; Vol. 156, pp. 113839. Date of Electronic Publication: 2022 Oct 11.
Autor:
Basak EA; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: e.basak@erasmusmc.nl., Vermeer NS; Dept. of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., de Joode K; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Hurkmans DP; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Velthuis DEM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Oomen-de Hoop E; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Schreurs MWJ; Dept. of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bins S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Debets R; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Veldt AAM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Aerts JGJV; Dept. of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands., Joosse A; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Oct; Vol. 174, pp. 113-120. Date of Electronic Publication: 2022 Aug 19.
Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors.
Autor:
Hurkmans DP; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands d.hurkmans@erasmusmc.nl.; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Sassen SDT; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., de Joode K; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Putter L; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Basak EA; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Wijkhuijs AJM; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Joerger M; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, The Netherlands., Debets R; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Koch BCP; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands., Schreurs MWJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus Universiteit Rotterdam, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Jun; Vol. 9 (6).
Autor:
Hurkmans DP; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands d.hurkmans@erasmusmc.nl shvdburg@lumc.nl.; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Verdegaal EME; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., Hogan SA; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., de Wijn R; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., Hovestad L; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., van den Heuvel DMA; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., Ruijtenbeek R; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., Welters MJP; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands., van Brakel M; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Pinedo HM; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., Lamers CHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., van de Werken HJG; Department of Urology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands.; Cancer Computational Biology Center, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Groten JP; PamGene International B.V, HH 's-Hertogenbosch, The Netherlands., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Levesque MP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Dummer R; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Burg SH; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, The Netherlands d.hurkmans@erasmusmc.nl shvdburg@lumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Dec; Vol. 8 (2).
Autor:
Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Meer JWM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hurkmans DP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Schreurs MWJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Oomen-de Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology and Nuclear Medicine, and Erasmus University Medical Center, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Joosse A; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Peeters RP; Department of Internal Medicine and Erasmus MC Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Medici M; Department of Internal Medicine and Erasmus MC Academic Center for Thyroid Diseases, Erasmus University Medical Center, Rotterdam, The Netherlands.; Department of Internal Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Thyroid : official journal of the American Thyroid Association [Thyroid] 2020 Jul; Vol. 30 (7), pp. 966-973. Date of Electronic Publication: 2020 Apr 23.
Autor:
Hurkmans DP; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands d.hurkmans@erasmusmc.nl.; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Schepers N; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Oomen-De Hoop E; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands., El Bouazzaoui S; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Departmemt of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van Schaik RHN; Department of Clinical Chemistry, Erasmus University Medical Center, Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus University Medical Center, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 May; Vol. 8 (1).
Autor:
Hurkmans DP; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. d.hurkmans@erasmusmc.nl.; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands. d.hurkmans@erasmusmc.nl., Basak EA; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., van Dijk T; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Mercieca D; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Schreurs MWJ; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Wijkhuijs AJM; Department of Immunology, Erasmus University Medical Center, Rotterdam, The Netherlands., Bins S; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Hoop EO; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Debets R; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Joerger M; Department of Medical Oncology and Hematology, Cantonal Hospital, St. Gallen, Switzerland., Odink A; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Department of Radiology & Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands., van der Leest CH; Department of Pulmonology, Amphia Hospital, Breda, The Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Mathijssen RHJ; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands., Koolen SLW; Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Center, PO Box 2040, 3000 CA, Rotterdam, The Netherlands.; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, The Netherlands.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jul 19; Vol. 7 (1), pp. 192. Date of Electronic Publication: 2019 Jul 19.
Autor:
Kunert A; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands. a.kunert@kitepharma.com.; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands. a.kunert@kitepharma.com., Basak EA; Laboratory of Translational Pharmacology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Hurkmans DP; Laboratory of Translational Pharmacology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Balcioglu HE; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands., Klaver Y; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands., van Brakel M; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands., Oostvogels AAM; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands., Lamers CHJ; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands., Bins S; Laboratory of Translational Pharmacology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Koolen SLW; Laboratory of Translational Pharmacology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van der Veldt AAM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Sleijfer S; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Mathijssen RHJ; Laboratory of Translational Pharmacology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Aerts JGJV; Department of Pulmonary Diseases, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Debets R; Laboratory of Tumor Immunology, Department of Medical Oncology, Erasmus MC Cancer Institute, Office Be 430b, Wytemaweg 80, 3015, CN, Rotterdam, The Netherlands. j.debets@erasmusmc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Jun 08; Vol. 7 (1), pp. 149. Date of Electronic Publication: 2019 Jun 08.
Autor:
Basak EA; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands. Electronic address: e.basak@erasmusmc.nl., Koolen SLW; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; Dept. of Hospital Pharmacy, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands., Hurkmans DP; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Schreurs MWJ; Dept. of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Bins S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Oomen-de Hoop E; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Wijkhuijs AJM; Dept. of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Besten ID; Dept. of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands., Sleijfer S; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Debets R; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., van der Veldt AAM; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Aerts JGJV; Dept. of Pulmonology, Erasmus University Medical Center, Rotterdam, the Netherlands., Mathijssen RHJ; Dept. of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2019 Mar; Vol. 109, pp. 12-20. Date of Electronic Publication: 2019 Jan 14.